Examining Promising Phase 2b PARADIGM Findings of ALS Agent PrimeC: Merit Cudkowicz, MD, MSc
WATCH TIME: 4 minutes "It’s important for clinicians to know that there is a big pipeline of therapies coming for trials in ALS, and they can become part of those clinical trials if they would like to. Also, it is essential for clinicians to make sure …